Advertisement

Ads Placeholder
Loading...

Cann Global Limited

CGB.AXASX
Healthcare
Drug Manufacturers - Specialty & Generic
$0.02
$0.00(0.00%)
Australian Market opens in 61h 27m

Cann Global Limited Fundamental Analysis

Cann Global Limited (CGB.AX) shows weak financial fundamentals with a PE ratio of -0.63, profit margin of -14.61%, and ROE of -60.88%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position178.33%
PEG Ratio-0.01
Current Ratio2.95

Areas of Concern

ROE-60.88%
Operating Margin-0.75%
We analyze CGB.AX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1409.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1409.0/100

We analyze CGB.AX's fundamental strength across five key dimensions:

Efficiency Score

Weak

CGB.AX struggles to generate sufficient returns from assets.

ROA > 10%
-62.48%

Valuation Score

Excellent

CGB.AX trades at attractive valuation levels.

PE < 25
-0.63
PEG Ratio < 2
-0.01

Growth Score

Weak

CGB.AX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

CGB.AX maintains a strong and stable balance sheet.

Debt/Equity < 1
0.03
Current Ratio > 1
2.95

Profitability Score

Weak

CGB.AX struggles to sustain strong margins.

ROE > 15%
-6087.87%
Net Margin ≥ 15%
-14.61%
Positive Free Cash Flow
No

Key Financial Metrics

Is CGB.AX Expensive or Cheap?

P/E Ratio

CGB.AX trades at -0.63 times earnings. This suggests potential undervaluation.

-0.63

PEG Ratio

When adjusting for growth, CGB.AX's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Cann Global Limited at 0.50 times its book value. This may indicate undervaluation.

0.50

EV/EBITDA

Enterprise value stands at -4.09 times EBITDA. This is generally considered low.

-4.09

How Well Does CGB.AX Make Money?

Net Profit Margin

For every $100 in sales, Cann Global Limited keeps $-14.61 as profit after all expenses.

-14.61%

Operating Margin

Core operations generate -0.75 in profit for every $100 in revenue, before interest and taxes.

-0.75%

ROE

Management delivers $-60.88 in profit for every $100 of shareholder equity.

-60.88%

ROA

Cann Global Limited generates $-62.48 in profit for every $100 in assets, demonstrating efficient asset deployment.

-62.48%

Following the Money - Real Cash Generation

Operating Cash Flow

Cann Global Limited generates limited operating cash flow of $-2.86K, signaling weaker underlying cash strength.

$-2.86K

Free Cash Flow

Cann Global Limited generates weak or negative free cash flow of $-107.21K, restricting financial flexibility.

$-107.21K

FCF Per Share

Each share generates $-0.00 in free cash annually.

$-0.00

FCF Yield

CGB.AX converts -1.76% of its market value into free cash.

-1.76%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.63

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.50

vs 25 benchmark

P/S Ratio

Price to sales ratio

9.98

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.03

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.95

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.61

vs 25 benchmark

ROA

Return on assets percentage

-0.62

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How CGB.AX Stacks Against Its Sector Peers

MetricCGB.AX ValueSector AveragePerformance
P/E Ratio-0.6328.54 Better (Cheaper)
ROE-60.88%738.00% Weak
Net Margin-1461.39%-43982.00% (disorted) Weak
Debt/Equity0.030.34 Strong (Low Leverage)
Current Ratio2.952806.01 Strong Liquidity
ROA-62.48%-14624.00% (disorted) Weak

CGB.AX outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cann Global Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ